Search details
1.
Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS.
J Neurovirol
; 23(4): 603-614, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28762183
2.
Sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1)-facilitated HIV restriction in astrocytes is regulated by miRNA-181a.
J Neuroinflammation
; 12: 66, 2015 Apr 08.
Article
in English
| MEDLINE | ID: mdl-25890101
3.
Towards nanomedicines for neuroAIDS.
Rev Med Virol
; 24(2): 103-24, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24395761
4.
Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.
Nanotechnology
; 25(5): 055101, 2014 Feb 07.
Article
in English
| MEDLINE | ID: mdl-24406534
5.
Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy.
J Immunol
; 186(11): 6173-81, 2011 Jun 01.
Article
in English
| MEDLINE | ID: mdl-21531891
6.
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.
J Infect Dis
; 206(11): 1715-23, 2012 Dec 01.
Article
in English
| MEDLINE | ID: mdl-23002445
7.
Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.
J Allergy Clin Immunol
; 128(6): 1279-85, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21752440
8.
MicroRNA: implications in HIV, a brief overview.
J Neurovirol
; 17(5): 416-23, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21786074
9.
Gene-expression reversal of lncRNAs and associated mRNAs expression in active vs latent HIV infection.
Sci Rep
; 6: 34862, 2016 10 19.
Article
in English
| MEDLINE | ID: mdl-27756902
10.
Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse.
Mol Brain
; 9(1): 57, 2016 05 23.
Article
in English
| MEDLINE | ID: mdl-27216740
11.
Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection.
Int J Nanomedicine
; 11: 4287-98, 2016.
Article
in English
| MEDLINE | ID: mdl-27621622
12.
Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages.
Sci Rep
; 6: 27864, 2016 06 20.
Article
in English
| MEDLINE | ID: mdl-27321752
13.
Interaction of drugs of abuse and microRNA with HIV: a brief review.
Front Microbiol
; 6: 967, 2015.
Article
in English
| MEDLINE | ID: mdl-26483757
14.
Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.
J Biomed Nanotechnol
; 11(10): 1722-33, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26502636
15.
Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.
Int J Nanomedicine
; 10: 5819-35, 2015.
Article
in English
| MEDLINE | ID: mdl-26425084
16.
Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting.
J Acquir Immune Defic Syndr
; 66(1): 16-24, 2014 May 01.
Article
in English
| MEDLINE | ID: mdl-24378729
17.
Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder.
Mol Brain
; 7: 37, 2014 May 15.
Article
in English
| MEDLINE | ID: mdl-24886748
18.
Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND).
PLoS One
; 8(4): e61399, 2013.
Article
in English
| MEDLINE | ID: mdl-23620748
19.
Inhibitors of HIV-1 entry and integration: recent developments and impact on treatment.
Recent Pat Inflamm Allergy Drug Discov
; 7(2): 151-61, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23578097
20.
Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.
PLoS One
; 8(4): e62241, 2013.
Article
in English
| MEDLINE | ID: mdl-23653680